Cambridge Investment Research Advisors, Inc. Jazz Pharmaceuticals PLC Transaction History

Cambridge Investment Research Advisors, Inc.

$29.9 Billion
Q4 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 5,437 shares of JAZZ stock, worth $762,376. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,437

Previous 6,215 12.52%

Holding current value

$762,376

Previous $692,000 3.18%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$107.32 - $127.74 $83,494 - $99,381	-778 Reduced 12.52%	5,437 $670,000
Q3 2024 Oct 28, 2024	BUY	$100.57 - $116.37 $19,007 - $21,993	189 Added 3.14%	6,215 $692,000
Q2 2024 Jul 26, 2024	BUY	$103.94 - $118.98 $626,342 - $716,973	6,026 New	6,026 $643,000
Q3 2023 Oct 24, 2023	SELL	$122.0 - $145.31 $55,754 - $66,406	-457 Reduced 19.06%	1,941 $251,000
Q2 2023 Jul 13, 2023	BUY	$122.5 - $147.16 $11,760 - $14,127	96 Added 4.17%	2,398 $297,000
Q1 2023 May 11, 2023	SELL	$133.98 - $160.47 $332,270 - $397,965	-2,480 Reduced 51.86%	2,302 $337,000
Q4 2022 Feb 08, 2023	BUY	$129.72 - $159.85 $141,135 - $173,916	1,088 Added 29.45%	4,782 $762,000
Q3 2022 Oct 17, 2022	BUY	$126.59 - $161.18 $4,304 - $5,480	34 Added 0.93%	3,694 $492,000
Q2 2022 Jul 13, 2022	SELL	$141.59 - $168.66 $11,893 - $14,167	-84 Reduced 2.24%	3,660 $570,000
Q1 2022 May 12, 2022	SELL	$129.64 - $160.7 $158,938 - $197,018	-1,226 Reduced 24.67%	3,744 $582,000
Q4 2021 Feb 03, 2022	SELL	$119.87 - $145.67 $118,311 - $143,776	-987 Reduced 16.57%	4,970 $633,000
Q3 2021 Nov 02, 2021	BUY	$128.64 - $184.79 $15,565 - $22,359	121 Added 2.07%	5,957 $775,000
Q2 2021 Aug 10, 2021	BUY	$160.2 - $186.42 $414,437 - $482,268	2,587 Added 79.62%	5,836 $1.04 Million
Q1 2021 May 07, 2021	SELL	$150.19 - $173.5 $260,429 - $300,849	-1,734 Reduced 34.8%	3,249 $534,000
Q4 2020 Feb 04, 2021	BUY	$140.71 - $165.05 $251,870 - $295,439	1,790 Added 56.06%	4,983 $822,000
Q3 2020 Oct 29, 2020	SELL	$105.46 - $144.13 $105 - $144	-1 Reduced 0.03%	3,193 $455,000
Q3 2019 Oct 28, 2019	BUY	$125.18 - $143.24 $26,913 - $30,796	215 Added 7.22%	3,194 $409,000
Q2 2019 Aug 15, 2019	BUY	$125.55 - $144.48 $374,013 - $430,405	2,979 New	2,979 $0
Q3 2018 Nov 02, 2018	SELL	$161.01 - $180.57 $258,421 - $289,814	-1,605 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$146.33 - $183.18 $234,859 - $294,003	1,605 New	1,605 $0
Q3 2017 Nov 07, 2017	SELL	$142.62 - $155.6 $208,510 - $227,487	-1,462 Closed	0 $0
Q2 2017 Aug 08, 2017	BUY	N/A	1,462	1,462 $227,000

Others Institutions Holding JAZZ

# of Institutions

543

Shares Held

59M

Call Options Held

125K

Put Options Held

58.4K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $8.79B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Jazz Pharmaceuticals PLC Transaction History